Abstract
Introduction: The College of American Pathologists (CAP) provides synoptic reporting (SR) histopathological protocols for various malignancies, e.g., for bladder cancer. We investigated whether SR can enhance the quality of histopathological reporting at our institution. Specifically, we examined whether SR supports pathologists in report preparation and whether urologists of varying training levels fully understand the histopathological information in narrative reports (NR). Methods: We investigated the transcription of semantic reports into synoptic CAP protocols by pathologists and clinicians. Through retrospective evaluation, 187 NR were re-evaluated using a CAP protocol by a senior pathologist to assess reporting quality and completeness. Additionally, 50 NR were independently transcribed into synoptic protocols by a resident trainee and board-certified urologists to evaluate clinical adoption. Results: SR demonstrated advantages in detailing specific pathological features, especially rare variants and tumor characteristics, despite high overall concordance between formats. Diagnostic accuracy improved with clinical experience, with uro-oncologist and department head outperforming the urology resident. Conclusions: SR has the potential to improve the communication between pathologists and urologists and enhance the quality of care. It also increased standardization and minimized omissions, highlighting its potential to reduce or eliminate information loss.
Journal Section:
Research Article
References
1.
Gontero
P
, Birtle
A
, Capoun
O
, Compérat
E
, Dominguez-Escrig
JL
, Liedberg
F
, et al. European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in Situ)-a summary of the 2024 guidelines update
. Eur Urol
. 2024
;86
(6
):531
–49
. 2.
Ferlay
J
, Colombet
M
, Soerjomataram
I
, Parkin
DM
, Piñeros
M
, Znaor
A
, et al. Cancer statistics for the year 2020: an overview
. Int J Cancer
. 2021
;149
(4
):778
–89
. 3.
Koch-Institut
R
. Krebs in Deutschland für 2019/2020
; 2023
[cited 2025 Mar 31]. Available from: https://edoc.rki.de/handle/176904/114384.
Dataset for histopathological reporting of tumours of the urinary collecting system (renal pelvis, ureter, urinary bladder and urethra)
.
(3rd ed)
. The Royal College of Pathologists
; 2021
[cited 2022 Oct 3]. Report No. G044. Available from: https://www.rcpath.org/static/e2c11ff6-780a-471e-a21a4dc48788d35b/Dataset-for-tumours-of-the-urinary-collecting-system.pdf5.
Urinary tract carcinoma - transurethral resection and biopsy structured reporting protocol
.
(1th ed)
. The Royal College of Pathologists
; 2018
[cited 2022 Dec 3]. Report No.: version 1.0. Available from: https://www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology-Reporting-of-Cancer/Cancer-Protocols/Genitourinary/Protocol-Bladder-TUR-and-Biopsy.aspx6.
Qualitätsrichtlinien SGPath: Ableitende Harnwege. Schweizerische Gesellschaft für Pathologie (SGPath). 2018. [cited 2022 Nov 20]. Available from: https://sgpath.ch/customer/files/231/Qualitaet-QRL-Ableitende-Harnwege-SGPath-2018.pdf
7.
Handleiding protocol blaas urethracarcinoom. Stichting palga. 2025. [cited 2025 Mar 21]. Report No.: Versie 68. Available from: https://www.palga.nl/media/uploads/pdf/5/6/563_blaasurethracarcinoom.pdf
8.
Varma
M
, Srigley
JR
, Brimo
F
, Compérat
E
, Delahunt
B
, Koch
M
, et al. Dataset for the reporting of urinary tract Carcinoma—biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)
. Mod Pathol
. 2020
;33
(4
):700
–12
. 9.
Protocol for the examination of biopsy and Transurethral Resection of Bladder Tumor (TURBT) specimens from patients with carcinoma of the urinary bladder
. College of American Pathologists (CAP)
; 2023
[cited 2023 Oct 10]. Report No.: Version: 4.2.0.0. Available from: https://documents.cap.org/protocols/Bladder.Bx.TURBT_4.2.0.0.REL_CAPCP.pdf10.
Ellis
DW
, Srigley
J
. Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence-based datasets
. Virchows Arch
. 2016
;468
(1
):51
–9
. 11.
Messenger
DE
, McLeod
RS
, Kirsch
R
. What impact has the introduction of a synoptic report for rectal cancer had on reporting outcomes for specialist gastrointestinal and nongastrointestinal pathologists
. Arch Pathol Lab Med
. 2011
;135
(11
):1471
–5
. 12.
Słodkowska
J
, Cierniak
S
, Patera
J
, Kopik
J
, Baranowski
W
, Markiewicz
T
, et al. Functional assessment of synoptic pathology reporting for ovarian cancer
. Pathobiology
. 2016
;83
(2–3
):70
–8
. 13.
Schaad
N
, Berezowska
S
, Perren
A
, Hewer
E
. Impact of template-based synoptic reporting on completeness of surgical pathology reports
. Virchows Arch
. 2024
;484
(1
):31
–6
. 14.
Lam
E
, Vy
N
, Bajdik
C
, Strugnell
SS
, Walker
B
, Wiseman
SM
. Synoptic pathology reporting for thyroid cancer: a review and institutional experience
. Expert Rev Anticancer Ther
. 2013
;13
(9
):1073
–9
. 15.
Hewer
E
, Rump
A
, Langer
R
. Standardisierte strukturierte Befundberichte gastrointestinaler tumoren
. Pathologe
. 2022
;43
(1
):57
–62
. 16.
Richter
C
, Mezger
E
, Schüffler
PJ
, Sommer
W
, Fusco
F
, Hauner
K
, et al. Pathological reporting of radical prostatectomy specimens following ICCR recommendation: impact of electronic reporting tool implementation on quality and interdisciplinary communication in a large university hospital
. Curr Oncol
. 2022
;29
(10
):7245
–56
. 17.
Sluijter
CE
, Van Lonkhuijzen
LRCW
, Van Slooten
HJ
, Nagtegaal
ID
, Overbeek
LIH
. The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review
. Virchows Arch
. 2016
;468
(6
):639
–49
. 18.
Renshaw
AA
, Gould
EW
. Comparison of accuracy and speed of information identification by nonpathologists in synoptic reports with different formats
. Arch Pathol Lab Med
. 2017
;141
(3
):418
–22
. 19.
Humphrey
PA
, Moch
H
, Cubilla
AL
, Ulbright
TM
, Reuter
VE
. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours
. Eur Urol
. 2016
;70
(1
):106
–19
. 20.
Shannon
CE
. A mathematical theory of communication
. Bell Syst Tech J
. 1948
;27
(3
):379
–423
. 21.
Jacobs
LG
, Pringle
MA
. Referral letters and replies from orthopaedic departments: opportunities missed
. BMJ
. 1990
;301
(6750
):470
–3
. 22.
Torous
VF
, Simpson
RW
, Balani
JP
, Baras
AS
, Berman
MA
, Birdsong
GG
, et al. College of American pathologists cancer protocols: from optimizing cancer patient care to facilitating interoperable reporting and downstream data use
. JCO Clin Cancer Inform
. 2021
;5
(5
):47
–55
. 23.
Van Berkum
MM
. SNOMED CT encoded cancer protocols
. AMIA Annu Symp Proc
. 2003
;2003
:1039
.24.
Pinto Dos Santos
D
, Baeßler
B
. Big data, artificial intelligence, and structured reporting
. Eur Radiol Exp
. 2018
;2
(1
):42
. 25.
Eloy
C
, Seegers
P
, Bazyleva
E
, Fraggetta
F
. The 1 million words pathology report or the challenge of a reproducible and meaningful message
. ESMO Real World Data Digital Oncol
. 2024
;4
:100044
. 26.
Zhang
DY
, Venkat
A
, Khasawneh
H
, Sali
R
, Zhang
V
, Pei
Z
. Implementation of digital pathology and artificial intelligence in routine pathology practice
. Lab Invest
. 2024
;104
(9
):102111
. 27.
Raciti
P
, Sue
J
, Retamero
JA
, Ceballos
R
, Godrich
R
, Kunz
JD
, et al. Clinical validation of artificial intelligence–augmented pathology diagnosis demonstrates significant gains in diagnostic accuracy in prostate cancer detection
. Arch Pathol Lab Med
. 2023
;147
(10
):1178
–85
. 28.
Malapelle
U
, Donne
AD
, Pagni
F
, Fraggetta
F
, Rocco
EG
, Pasello
G
, et al. Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: practical indications from an Italian multidisciplinary group
. Crit Rev Oncol Hematol
. 2024
;193
:104217
. 29.
Swillens
JEM
, Sluijter
CE
, Overbeek
LIH
, Nagtegaal
ID
, Hermens
RPMG
. Identification of barriers and facilitators in nationwide implementation of standardized structured reporting in pathology: a mixed method study
. Virchows Arch
. 2019
;475
(5
):551
–61
. 30.
Bazyleva
E
, De Schutter
H
, Croes
R
, Deman
F
, Roose
E
, Van De Vijver
K
, et al. Obstacles and drivers in the adoption of standardized structured reporting (SSR): insights from pathologists
. Virchows Arch
. 2025
;487
(1
):163
–73
. 31.
Holden
JD
. Hawthorne effects and research into professional practice
. J Eval Clin Pract
. 2001
;7
(1
):65
–70
. 32.
Hallek
M
, Ockenfels
A
, Wiesen
D
. Behavioral economics interventions to improve medical decision-making
. Dtsch Arztebl Int
. 2022
;119
(38
):633
–9
. 33.
De Neree Tot Babberich
MPM
, Ledeboer
M
, Van Leerdam
ME
, Spaander
MCW
, Van Esch
AAJ
, Ouwendijk
RJ
, et al. Dutch gastrointestinal endoscopy audit: automated extraction of colonoscopy data for quality assessment and improvement
. Gastrointest Endosc
. 2020
;92
(1
):154
–62.e1
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
